Integra LifeSciences Holdings (IART)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -6,943 -6,544 23,648 40,234 67,741 100,853 131,271 171,875 180,550 172,988 166,302 156,582 169,075 216,435 205,543 170,106 133,892 56,467 -3,480 26,625
Total assets US$ in thousands 4,037,420 4,065,800 4,074,500 4,078,220 3,781,990 3,739,370 3,777,600 3,742,400 3,889,760 3,807,010 3,752,860 3,672,000 3,782,380 3,774,460 3,712,790 3,741,550 3,615,140 3,453,520 3,391,760 3,447,560
ROA -0.17% -0.16% 0.58% 0.99% 1.79% 2.70% 3.47% 4.59% 4.64% 4.54% 4.43% 4.26% 4.47% 5.73% 5.54% 4.55% 3.70% 1.64% -0.10% 0.77%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-6,943K ÷ $4,037,420K
= -0.17%

The return on assets (ROA) of Integra LifeSciences Holdings has displayed some volatility over the period from March 31, 2020, to December 31, 2024. The ratio indicates the company's ability to generate profits relative to its total assets.

The ROA started at a modest 0.77% on March 31, 2020, but turned negative at -0.10% by June 30, 2020. From there, it showed a significant improvement, reaching 5.73% on September 30, 2021, its highest point during the period analyzed. Subsequently, the ROA fluctuated between 4.26% and 0.58%, with some periods of decline such as on September 30, 2024, when the ratio turned negative at -0.16% and then decreased further to -0.17% by December 31, 2024.

Overall, the ROA trend of Integra LifeSciences Holdings indicates varying levels of efficiency in utilizing its assets to generate profits. An increasing ROA signifies that the company is becoming more efficient in generating earnings from its assets, while a decreasing or negative ROA can indicate potential issues with asset utilization or profitability. It would be important to further investigate the factors contributing to the fluctuations in ROA to assess the company's financial performance and operational effectiveness.